Biomarker Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
Trends, opportunities and forecast in biomarker market to 2025 by product (consumables and service), type (safety, efficacy, and validation), disease indication (cancer and cardiovascular disorders), application (diagnostics development, drug discovery & development, and disease risk), and region (North America, Europe, Asia Pacific, and Rest of the World)
Trends, opportunities and forecast in biomarker market to 2025 by product (consumables and service), type (safety, efficacy, and validation), disease indication (cancer and cardiovascular disorders), application (diagnostics development, drug discovery & development, and disease risk), and region (North America, Europe, Asia Pacific, and Rest of the World)
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biomarker Market Trends and Forecast
3.3: Global Biomarker Market by Product
3.3.1: Consumables
3.3.2: Services
3.4: Global Biomarker Market by Type
3.4.1: Safety
3.4.2: Efficacy
3.4.3: Validation
3.5: Global Biomarker Market by Disease Indication
3.5.1: Cancer
3.5.2: Cardiovascular Disorders
3.6: Global Biomarker Market by Application
3.6.1: Diagnostics Development
3.6.2: Drug Discovery and Development
3.6.3: Disease Risk
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Biomarker Market by Region
4.2: North American Biomarker Market
4.2.1: Market by Product: Consumables and Service
4.2.2: Market by Type: Safety, Efficacy, and Validation
4.2.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.2.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.2.5: The United States Biomarker Market
4.2.6: The Canadian Biomarker Market
4.2.7: The Mexican Biomarker Market
4.3: European Biomarker Market
4.3.1: Market by Product: Consumables and Service
4.3.2: Market by Type: Safety, Efficacy, and Validation
4.3.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.3.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.3.5: The Biomarker Market of the United Kingdom
4.3.6: The German Biomarker Market
4.3.7: The French Biomarker Market
4.4: APAC Biomarker Market
4.4.1: Market by Product: Consumables and Service
4.4.2: Market by Type: Safety, Efficacy, and Validation
4.4.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.4.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.4.5: The Chinese Biomarker Market
4.4.6: The Indian Biomarker Market
4.4.7: The Japanese Biomarker Market
4.5: ROW Biomarker Market
4.5.1: Market by Product: Consumables and Service
4.5.2: Market by Type: Safety, Efficacy, and Validation
4.5.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.5.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.5.5: Brazilian Biomarker Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biomarker Market by Product
7.1.2: Growth Opportunities for the Global Biomarker Market by Type
7.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
7.1.4: Growth Opportunities for the Global Biomarker Market by Application
7.1.5: Growth Opportunities for the Global Biomarker Market by Region
7.2: Emerging Trends in the Global Biomarker Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biomarker Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Qiagen N.V.
8.2: Perkinelmer, Inc.
8.3: Merck Millipore
8.4: Bio-Rad Laboratories, Inc.
8.5: Enz Biochem, Inc.
8.6: EKF Diagnostics Holdings, Inc.
8.7: Mes Scale Diagnostics, LLC.
8.8: Biosims Technologies Sas
8.9: Cisbi Bioassays
8.10: Signosis, Inc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biomarker Market Trends and Forecast
3.3: Global Biomarker Market by Product
3.3.1: Consumables
3.3.2: Services
3.4: Global Biomarker Market by Type
3.4.1: Safety
3.4.2: Efficacy
3.4.3: Validation
3.5: Global Biomarker Market by Disease Indication
3.5.1: Cancer
3.5.2: Cardiovascular Disorders
3.6: Global Biomarker Market by Application
3.6.1: Diagnostics Development
3.6.2: Drug Discovery and Development
3.6.3: Disease Risk
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Biomarker Market by Region
4.2: North American Biomarker Market
4.2.1: Market by Product: Consumables and Service
4.2.2: Market by Type: Safety, Efficacy, and Validation
4.2.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.2.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.2.5: The United States Biomarker Market
4.2.6: The Canadian Biomarker Market
4.2.7: The Mexican Biomarker Market
4.3: European Biomarker Market
4.3.1: Market by Product: Consumables and Service
4.3.2: Market by Type: Safety, Efficacy, and Validation
4.3.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.3.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.3.5: The Biomarker Market of the United Kingdom
4.3.6: The German Biomarker Market
4.3.7: The French Biomarker Market
4.4: APAC Biomarker Market
4.4.1: Market by Product: Consumables and Service
4.4.2: Market by Type: Safety, Efficacy, and Validation
4.4.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.4.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.4.5: The Chinese Biomarker Market
4.4.6: The Indian Biomarker Market
4.4.7: The Japanese Biomarker Market
4.5: ROW Biomarker Market
4.5.1: Market by Product: Consumables and Service
4.5.2: Market by Type: Safety, Efficacy, and Validation
4.5.3: Market by Disease Indication: Cancer and Cardiovascular Disorders
4.5.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk
4.5.5: Brazilian Biomarker Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biomarker Market by Product
7.1.2: Growth Opportunities for the Global Biomarker Market by Type
7.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
7.1.4: Growth Opportunities for the Global Biomarker Market by Application
7.1.5: Growth Opportunities for the Global Biomarker Market by Region
7.2: Emerging Trends in the Global Biomarker Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biomarker Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Qiagen N.V.
8.2: Perkinelmer, Inc.
8.3: Merck Millipore
8.4: Bio-Rad Laboratories, Inc.
8.5: Enz Biochem, Inc.
8.6: EKF Diagnostics Holdings, Inc.
8.7: Mes Scale Diagnostics, LLC.
8.8: Biosims Technologies Sas
8.9: Cisbi Bioassays
8.10: Signosis, Inc.
